Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

The Shockwave / GAINSWave Device Market

Low-intensity shockwave for ED, FDA-clearance reality, clinic franchises, paid influencers

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
No device is FDA-approved/cleared for ED; AUA calls Li-ESWT investigational

Reference only. Not medical advice.

What can go wrong

Physical risk is low (it is non-invasive), but the financial and expectation risks are real: patients pay thousands out of pocket for an investigational therapy that may not work for them. 'Radial wave' machines marketed as shockwave deliver a lower-energy pressure wave that differs from the focused devices used in most positive studies, a clinically meaningful bait-and-switch in some clinics.

This is something to take to a clinician. The Atlas can tell you what is known about the shockwave / gainswave device market in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Low-intensity extracorporeal shockwave therapy (Li-ESWT) for ED is sold through branded protocols like GAINSWave and a growing network of cash-pay clinics. The critical fact the marketing blurs: no shockwave device is FDA-approved or cleared for treating ED. Devices may hold FDA clearance for unrelated indications (e.g., musculoskeletal/wound applications), and ED use is off-label. The 2018 AUA guideline classifies Li-ESWT for ED as investigational (conditional recommendation, evidence grade C). Sham-controlled trials are mixed.

Marketed as a cure, classified by the AUA as investigational.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Marketed for vasculogenic ED
  • Marketed for 'sexual wellness/optimization'
  • Cash-pay clinic packages

How it is supposed to work

The proposed mechanism is mechanotransduction: focused acoustic pulses are hypothesized to trigger neovascularization (angiogenesis) and recruit endothelial/stem-cell repair in penile vasculature, potentially improving blood flow. This is biologically plausible and supported by some preclinical work, but the magnitude and durability of benefit in humans remains uncertain, and protocols (energy, focused vs radial, session count) are not standardized.

FDA-cleared device does not mean FDA-cleared for ED

Clinics often advertise an 'FDA-cleared device.' That clearance is typically for a different indication (such as musculoskeletal pain or wound healing). Using the device for ED is off-label, and the ED indication itself is not FDA-approved. Marketing that conflates device clearance with proof of ED efficacy is misleading.

Safety in detail

Low-intensity shockwave for ED is an investigational therapy not FDA-approved/cleared for this use; the 2018 AUA guideline recommends it be considered investigational and ideally offered under research protocols. Patients should be counseled that benefit is unproven and not covered by insurance.

What people get wrong

  • Often saidShockwave is an FDA-approved cure for ED

    ActuallyNo shockwave device is FDA-approved/cleared for ED. The AUA classifies it as investigational. Some devices are cleared for unrelated indications only.

  • Often saidAll 'shockwave' clinics use the same technology

    ActuallyFocused shockwave (used in most positive trials) differs from lower-energy radial 'pressure-wave' machines that some clinics substitute.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

FDA status for ED
No device approved/cleared for ED; ED use is off-label
AUA 2018
Li-ESWT for ED is investigational (Grade C)
Typical clinic price
~$400-$500/session; packages ~$2,400-$6,000
Device types
Focused vs radial (radial 'shockwave' is lower-energy pressure wave)

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about The Shockwave / GAINSWave Device Market. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • AUA Erectile Dysfunction Guideline (Li-ESWT statement)2018

    Low-intensity shockwave for ED should be considered investigational; conditional recommendation, evidence grade C